title: 4-Azatricyclo[5.2.2.02,6]undecane-3,5,8-triones as potential pharmacological agents.
abstract: A series of twenty six arylpiperazine and aminoalkanol derivatives of 4-azatricyclo[5.2.2.0(2,6)]undecane-3,5,8-trione have been prepared. The synthesized compounds were evaluated for their cytotoxicity and anti-HIV-1 activity in MT-4 cells.
authors.affiliation: Department of Medical Chemistry, The Medical University of Warsaw, 3 Oczki Street, 02-007 Warsaw, Poland.
authors.forename: Jerzy
authors.initials: J
authors.lastname: Kossakowski
authors.forename: Anna
authors.initials: A
authors.lastname: Bielenica
authors.forename: Barbara
authors.initials: B
authors.lastname: Mirosław
authors.forename: Anna E
authors.initials: AE
authors.lastname: Kozioł
authors.forename: Izabela
authors.initials: I
authors.lastname: Dybała
authors.forename: Marta
authors.initials: M
authors.lastname: Struga
mesh_terms: D000438:Alcohols / Q000737:chemistry / Q000494:pharmacology*; D000473:Alkanes / Q000737:chemistry / Q000494:pharmacology; D019380:Anti-HIV Agents / Q000737:chemistry* / Q000494:pharmacology; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects; D004354:Drug Screening Assays, Antitumor; D006801:Humans; D010879:Piperazines / Q000737:chemistry / Q000494:pharmacology*; D013329:Structure-Activity Relationship
chemical_list: D000438:Alcohols; D000473:Alkanes; D019380:Anti-HIV Agents; D010879:Piperazines; C022884:undecane
references.citation: J Infect Dis. 2007 Jul 15;196(2):304-12
references.pmid: 17570119
references.citation: JAMA. 1998 Jul 1;280(1):78-86
references.pmid: 9660368
references.citation: Chem Pharm Bull (Tokyo). 2001 Nov;49(11):1406-11
references.pmid: 11724230
references.citation: Pol J Pharmacol. 2004 Nov-Dec;56(6):843-8
references.pmid: 15662099
references.citation: Bioorg Med Chem. 2006 Apr 15;14(8):2828-36
references.pmid: 16376083
references.citation: Bioorg Med Chem. 2004 Aug 15;12(16):4361-73
references.pmid: 15265488
references.citation: Eur J Med Chem. 2006 Jul;41(7):874-81
references.pmid: 16600439
references.citation: J Med Chem. 1993 May 14;36(10):1505-8
references.pmid: 7684450
references.citation: Curr Drug Targets Infect Disord. 2004 Jun;4(2):111-6
references.pmid: 15180459
references.citation: Bioorg Med Chem Lett. 2004 Apr 5;14(7):1709-12
references.pmid: 15026055
references.citation: J Med Chem. 2004 Aug 26;47(18):4453-62
references.pmid: 15317457
references.citation: Ceska Slov Farm. 2000 Jul;49(4):177-80
references.pmid: 10953467
references.citation: Bioorg Med Chem Lett. 2000 Mar 6;10(5):465-8
references.pmid: 10743949
references.citation: Bioorg Med Chem Lett. 2004 Aug 16;14(16):4287-90
references.pmid: 15261288
references.citation: J Virol Methods. 1988 Aug;20(4):309-21
references.pmid: 2460479
references.citation: Eur J Med Chem. 2007 Mar;42(3):293-306
references.pmid: 17254669
references.citation: Bioorg Med Chem Lett. 2005 Oct 15;15(20):4488-92
references.pmid: 16105736
references.citation: J Med Chem. 2004 May 6;47(10):2405-8
references.pmid: 15115380